Covington Capital Management - INMUNE BIO INC ownership

INMUNE BIO INC's ticker is INMB and the CUSIP is 45782T105. A total of 14 filers reported holding INMUNE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Covington Capital Management ownership history of INMUNE BIO INC
ValueSharesWeighting
Q3 2022$6,000
-33.3%
1,0000.0%0.00%
Q2 2022$9,000
+12.5%
1,0000.0%0.00%
Q1 2022$8,000
-20.0%
1,0000.0%0.00%
Q4 2021$10,000
-47.4%
1,0000.0%0.00%
-100.0%
Q3 2021$19,000
+5.6%
1,0000.0%0.00%0.0%
Q2 2021$18,000
+50.0%
1,0000.0%0.00%0.0%
Q1 2021$12,000
-29.4%
1,0000.0%0.00%0.0%
Q4 2020$17,000
+70.0%
1,0000.0%0.00%
Q3 2020$10,000
+100.0%
1,0000.0%0.00%
Q2 2020$5,000
+66.7%
1,0000.0%0.00%
Q1 2020$3,000
-50.0%
1,0000.0%0.00%
Q4 2019$6,0000.0%1,0000.0%0.00%
Q3 2019$6,0001,0000.00%
Other shareholders
INMUNE BIO INC shareholders Q1 2020
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 230,500$2,351,0001.70%
Fermata Advisors, LLC 17,955$183,0000.07%
Virtu Financial LLC 24,364$249,0000.02%
YorkBridge Wealth Partners, LLC 10,369$106,0000.02%
Jump Financial, LLC 21,100$215,0000.01%
Financial Advocates Investment Management 15,167$155,0000.01%
FNY Investment Advisers, LLC 1,100$11,0000.01%
Janney Montgomery Scott LLC 113,914$1,162,0000.01%
Walleye Capital LLC 17,127$175,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 12,473$127,0000.00%
View complete list of INMUNE BIO INC shareholders